This post was originally published on this site
After three back-to-back miscarriages, Brittany Gould said she turned to Theranos Inc. to know if her latest pregnancy was on track.
Then, one of the company’s trademark finger-prick tests indicated she was losing another baby, Ms. Gould said. The Mesa, Ariz., medical assistant recalled dreading the moment when she would have to tell her 7-year-old daughter, who was waiting for a sibling.
“Mommy is not having a baby,” Ms. Gould said she told her.
Like those of other patients slated as potential witnesses in the criminal trial of Theranos founder Elizabeth Holmes , Ms. Gould’s test was wrong. Prosecutors have accused Ms. Holmes of defrauding patients and investors by falsely claiming her invention could accurately perform lab tests on just a few drops of blood.
An expanded version of this article appears on WSJ.com.
Popular stories from WSJ.com: